Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DNM3OS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RAB9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTCH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBE2D2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC110 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LHX9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on